- Radboud Repository
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Verheugt, F.W.A."
Now showing items 1-50 of 544
-
-
-
Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial Washam, J.B.; Hohnloser, S.H.; Lopes, R.D.; Wojdyla, D.M.; Vinereanu, D.; Alexander, J.H.; Gersh, B.J.; Hanna, M.; Horowitz, J.; Hylek, E.M.; et al.2019, Article / Letter to editor (Journal of Thrombosis and Thrombolysis, vol. 47, iss. 3, (2019), pp. 345-352)
sine al.
-
-
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations Caterina, R. De; Ageno, W.; Agnelli, G.; Chan, N.C.; Diener, H.C.; Hylek, E.; Raskob, G.E.; Siegal, D.M.; ; Lip, G.Y.H.; et al.2019, Article / Letter to editor (Thrombosis and Haemostasis, vol. 119, iss. 1, (2019), pp. 14-38)
sine al.
-
Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention Kerneis, M.; Yee, M.K.; Mehran, R.; Nafee, T.; Bode, C.; Halperin, J.L.; Peterson, E.D.; ; Wildgoose, P.; Eickels, M. van; et al.2019, Article / Letter to editor (Circulation-Cardiovascular Interventions, vol. 12, iss. 2, (2019), pp. e007124)
sine al.
-
International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin Guimaraes, P.O.; Lopes, R.D.; Alexander, J.H.; Thomas, L.; Hellkamp, A.S.; Hijazi, Z.; Hylek, E.M.; Gersh, B.J.; Garcia, D.A.; ; et al.2019, Article / Letter to editor (Journal of Thrombosis and Thrombolysis, vol. 48, iss. 1, (2019), pp. 27-34)
sine al.
-
-
-
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis) Korjian, S.; Daaboul, Y.; Laliberte, F.; Zhao, Q.; Mehran, R.; Bode, C.; Halperin, J.; ; Lip, G.Y.H.; Cohen, M.; et al.2019, Article / Letter to editor (American Journal of Cardiology, vol. 123, iss. 3, (2019), pp. 355-360)
sine al.
-
-
-
-
Association between Lifelong Physical Activity and Disease Characteristics in HCM Aengevaeren, V.L.; Gommans, D.H.F.; ; ; ; Bakker, Jeannette; ; ; ; ; et al.2019, Article / Letter to editor (Medicine and Science in Sports and Exercise, vol. 51, iss. 10, (2019), pp. 1995-2002)
sine al.
-
-
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry Corbalan, R.; Bassand, J.P.; Illingworth, L.; Ambrosio, G.; Camm, A.J.; Fitzmaurice, D.A.; Fox, K.A.; Goldhaber, S.Z.; Goto, S.; Haas, S.; et al.2019, Article / Letter to editor (JAMA Cardiology, vol. 4, iss. 6, (2019), pp. 526-548)
sine al.
-
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation Bassand, J.P.; Virdone, S.; Goldhaber, S.Z.; Camm, A.J.; Fitzmaurice, D.A.; Fox, K.A.; Goto, S.; Haas, S.; Hacke, W.; Kayani, G.; et al.2019, Article / Letter to editor (Circulation, vol. 139, iss. 6, (2019), pp. 787-798)
sine al.
-
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF Haas, S.; Camm, A.J.; Bassand, J.P.; Angchaisuksiri, P.; Cools, F.; Corbalan, R.; Gibbs, H.; Jacobson, B.; Koretsune, Y.; Mantovani, L.G.; et al.2019, Article / Letter to editor (American Heart Journal, vol. 213, (2019), pp. 35-46)
sine al.
-
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS) Valgimigli, M.; Bueno, H.; Byrne, R.A.; Collet, J.P.; Costa, F.; Jeppsson, A.; Juni, P.; Kastrati, A.; Kolh, P.; Mauri, L.; et al.2018, Article / Letter to editor (European Heart Journal, vol. 39, iss. 3, (2018), pp. 213-260)
sine al.
-
Safety and efficacy of non-vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial Chi, G.; Kerneis, M.; Kalayci, A.; Liu, Y; Mehran, R.; Bode, C.; Halperin, J.L.; ; Wildgoose, P.; Eickels, M. van; et al.2018, Article / Letter to editor (American Heart Journal, vol. 203, (2018), pp. 17-24)
sine al.
-
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS Valgimigli, M.; Bueno, H.; Byrne, R.A.; Collet, J.P.; Costa, F.; Jeppsson, A.; Juni, P.; Kastrati, A.; Kolh, P.; Mauri, L.; et al.2018, Article / Letter to editor (European Journal of Cardio-Thoracic Surgery, vol. 53, iss. 1, (2018), pp. 34-78)
sine al.
-
High T2-weighted signal intensity for risk prediction of sudden cardiac death in hypertrophic cardiomyopathy Gommans, D.H.F.; ; Bakker, Jeannette; ; Michels, Michelle; Fouraux, Michael A.; ; ; ; ; et al.2018, Article / Letter to editor (International Journal of Cardiovascular Imaging, vol. 34, iss. 1, (2018), pp. 113-120)
sine al.
-
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry ; Gao, H.; Mahmeed, W. Al; Ambrosio, G.; Angchaisuksiri, P.; Atar, D.; Bassand, J.P.; Camm, A.J.; Cools, F.; Eikelboom, J.; et al.2018, Article / Letter to editor (European Heart Journal, vol. 39, iss. 6, (2018), pp. 464-473)
sine al.
-
-
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis Rocca, B.; Fox, K.A.; Ajjan, R.A.; Andreotti, F.; Baigent, C.; Collet, J.P.; Grove, E.L.; Halvorsen, S.; Huber, K.; Morais, J.; et al.2018, Article / Letter to editor (European Heart Journal, vol. 39, iss. 19, (2018), pp. 1672-1691)
sine al.
-
-
Prediction of Extensive Myocardial Fibrosis in Nonhigh Risk Patients With Hypertrophic Cardiomyopathy Gommans, D.H.F.; ; Fouraux, M.A.; Bakker, J. den; Michels, M; ; ; ; ; ; et al.2018, Article / Letter to editor (American Journal of Cardiology, vol. 122, iss. 3, (2018), pp. 483-489)
sine al.
-
Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial Kopin, D.; Jones, W.S.; Sherwood, M.W.; Wojdyla, D.M.; Wallentin, L.; Lewis, B.S.; ; Vinereanu, D.; Bahit, M.C.; Halvorsen, S.; et al.2018, Article / Letter to editor (American Heart Journal, vol. 197, (2018), pp. 133-141)
sine al.
-
Total bleeding with rivaroxaban versus warfarin in patients with atrial fibrillation receiving antiplatelet therapy after percutaneous coronary intervention Chi, G.; Yee, M.K.; Kalayci, A.; Kerneis, M.; AlKhalfan, F.; Mehran, R.; Bode, C.; Halperin, J.L.; ; Wildgoose, P.; et al.2018, Article / Letter to editor (Journal of Thrombosis and Thrombolysis, vol. 46, iss. 3, (2018), pp. 346-350)
sine al.
-
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy Siller-Matula, J.M.; Pecen, L.; Patti, G.; Lucerna, M.; Kirchhof, P.; Lesiak, M.; Huber, K.; ; Lang, I.M.; Renda, G.; et al.2018, Article / Letter to editor (International Journal of Cardiology, vol. 265, (2018), pp. 141-147)
sine al.
-
-
-
-
Individual participant data analysis of two trials on aldosterone blockade in myocardial infarction Beygui, F.; Belle, E. van; Ecollan, P.; Machecourt, J.; Hamm, C.W.; Sa, E. Lopez De; Flather, M.; ; Vicaut, E.; Zannad, F.; et al.2018, Article / Letter to editor (Heart, vol. 104, iss. 22, (2018), pp. 1843-1849)
sine al.
-
-
-
Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial Kerneis, M.; Gibson, C.M.; Chi, G.; Mehran, R.; AlKhalfan, F.; Talib, U.; Pahlavani, S.; Mir, M.; Bode, C.; Halperin, J.L.; et al.2018, Article / Letter to editor (Jacc. Cardiovascular Interventions, vol. 11, iss. 7, (2018), pp. 626-634)
sine al.
-
Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study Ferreira, J.P.; Duarte, K.; Montalescot, G.; Pitt, B.; Sa, E.L. de; Hamm, C.W.; Flather, M.; ; Shi, H.; Turgonyi, E.; et al.2018, Article / Letter to editor (Clinical Research in Cardiology, vol. 107, iss. 1, (2018), pp. 49-59)
sine al.
-
Collagen biomarker bioprofiles predicting the antifibrotic response to eplerenone in myocardial infarction: findings from the REMINDER trial Ferreira, J.P.; Barros, A.; Pitt, B.; Montalescot, G.; Sa, E.L. de; Hamm, C.W.; Flather, M.; ; Shi, H.; Leite-Moreira, A.; et al.2018, Article / Letter to editor (Clinical Research in Cardiology, vol. 107, iss. 12, (2018), pp. 1192-1195)
sine al.
-
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation Bassand, J.P.; Accetta, G.; Mahmeed, W. Al; Corbalan, R.; Eikelboom, J.; Fitzmaurice, D.A.; Fox, K.A.; Gao, H.; Goldhaber, S.Z.; Goto, S.; et al.2018, Article / Letter to editor (PLoS One, vol. 13, iss. 1, (2018), article e0191592)
sine al.
-
-
-
-
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial Hu, P.T.; Lopes, R.D.; Stevens, S.R.; Wallentin, L.; Thomas, L.; Alexander, J.H.; Hanna, M.; Lewis, B.S.; ; Granger, C.B.; et al.2017, Article / Letter to editor (Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, vol. 6, iss. 1, (2017), article e004699)
sine al.
-
-
Early clinical outcomes as a function of use of newer oral P2Y12 inhibitors versus clopidogrel in the EUROMAX trial Huber, K.; Ducrocq, G.; Hamm, C.W.; Hof, A. van't; Lapostolle, F.; Coste, P.; Gordini, G.; Steinmetz, J.; ; Adgey, J.; et al.2017, Article / Letter to editor (Open Heart, vol. 4, iss. 2, (2017), article e000677)
sine al.
-
-
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis Niessner, A.; Tamargo, J.; Morais, J.; Koller, L.; Wassmann, S.; Husted, S.E.; Torp-Pedersen, C.; Kjeldsen, K.; Lewis, B.S.; Drexel, H.; et al.2017, Article / Letter to editor (European Heart Journal, vol. 38, iss. 22, (2017), pp. 1710-1716)
sine al.
-
-
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis Halvorsen, S.; Storey, R.F.; Rocca, B.; Sibbing, D.; Grove, E.L.; Weiss, T.W.; Collet, J.P.; Andreotti, F.; Gulba, D.C.; Lip, G.Y.; et al.2017, Article / Letter to editor (European Heart Journal, vol. 38, iss. 19, (2017), pp. 1455-1462)
sine al.
Now showing items 1-50 of 544
Upload Full Text